Synthesis and in vivo imaging properties of [11C]befloxatone: a novel highly potent positron emission tomography ligand for mono-amine oxidase-A |
| |
Authors: | Dolle Frédéric Valette Héric Bramoulle Yann Guenther Ilonka Fuseau Chantal Coulon Christine Lartizien Carole Jegham Samir George Pascal Curet Olivier Pinquier Jean-Louis Bottlaender Michel |
| |
Institution: | Service Hospitalier Frédéric Joliot, Département de Recherche Médicale, CEA/DSV, 4 place du Général Leclerc, F-91406 Orsay, France. dolle@dsvidf.cea.fr |
| |
Abstract: | Befloxatone (1, (5R)-5-(methoxymethyl)-3-4-(3R)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone) is an oxazolidinone derivative belonging to a new generation of reversible and selective mono-amine oxidase-A (MAO-A) inhibitors. In vitro and ex vivo studies have demonstrated that befloxatone is a potent, reversible and competitive MAO-A inhibitor with potential antidepressant properties. Befloxatone (1) was labelled with carbon-11 (t(12): 20.4 min) using (11)C]phosgene as reagent. Typically, starting from a 1.2 Ci (44.4 GBq) cyclotron-produced (11)C]CH(4) batch, 150-300 mCi (5.55-11.10 GBq) of (11)C]befloxatone ((11)C]-1) with a radiochemical- and chemical purity of more than 99% were routinely obtained within 20 min of radiosynthesis (including HPLC purification) with specific radioactivities of 500-2000 mCi/micromol (18.5-74.0 GBq/micromol). The results obtained in vivo with carbon-11-labelled befloxatone not only confirm the biochemical and pharmacological profile of befloxatone found in rodent and in human tissues but also point out (11)C]befloxatone as an excellent tool for the assessment of MAO-A binding sites using positron emission tomography, a high-resolution, sensitive, non-invasive and quantitative imaging technique. |
| |
Keywords: | |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|